rb 6145 has been researched along with lomustine in 2 studies
| Studies (rb 6145) | Trials (rb 6145) | Recent Studies (post-2010) (rb 6145) | Studies (lomustine) | Trials (lomustine) | Recent Studies (post-2010) (lomustine) |
|---|---|---|---|---|---|
| 38 | 0 | 2 | 1,975 | 492 | 274 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siemann, DW | 2 |
2 other study(ies) available for rb 6145 and lomustine
| Article | Year |
|---|---|
Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 144872.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Lomustine; Mice; Nitroimidazoles; Prodrugs; Sarcoma, Experimental; Stereoisomerism; Tumor Cells, Cultured | 1995 |
In vitro cytotoxicity and chemosensitizing activity of the dual function nitroimidazole RB 6145.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Humans; Lomustine; Mice; Nitroimidazoles; Prodrugs; Stereoisomerism; Tumor Cells, Cultured | 1994 |